Lord, Abbett & Co. LLC Conmed Corp Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 07, 2024	SELL	$75.36 - $112.51 $17,935 - $26,777	-238 Reduced 0.16%	147,620 $11.8 Million
Q1 2024 May 09, 2024	SELL	$75.36 - $112.51 $17,935 - $26,777	-238 Reduced 0.16%	147,620 $11.8 Million
Q4 2023 Oct 07, 2024	SELL	$91.3 - $115.05 $3.12 Million - $3.94 Million	-34,205 Reduced 18.79%	147,858 $16.2 Million
Q4 2023 Feb 12, 2024	SELL	$91.3 - $115.05 $3.12 Million - $3.94 Million	-34,205 Reduced 18.79%	147,858 $16.2 Million
Q3 2023 Oct 07, 2024	SELL	$97.55 - $135.91 $305,331 - $425,398	-3,130 Reduced 1.69%	182,063 $18.4 Million
Q3 2023 Nov 13, 2023	SELL	$97.55 - $135.91 $305,331 - $425,398	-3,130 Reduced 1.69%	182,063 $18.4 Million
Q2 2023 Oct 07, 2024	SELL	$102.55 - $136.38 $14.9 Million - $19.8 Million	-145,133 Reduced 43.94%	185,193 $25.2 Million
Q2 2023 Aug 14, 2023	SELL	$102.55 - $136.38 $14.9 Million - $19.8 Million	-145,133 Reduced 43.94%	185,193 $25.2 Million
Q1 2023 Oct 07, 2024	BUY	$89.75 - $107.27 $369,500 - $441,630	4,117 Added 1.26%	330,326 $34.3 Million
Q1 2023 May 12, 2023	BUY	$89.75 - $107.27 $369,500 - $441,630	4,117 Added 1.26%	330,326 $34.3 Million
Q4 2022 Oct 07, 2024	BUY	$72.84 - $94.04 $23.8 Million - $30.7 Million	326,209 New	326,209 $28.9 Million
Q4 2022 Feb 10, 2023	SELL	$72.84 - $94.04 $103,068 - $133,066	-1,415 Reduced 0.43%	326,209 $28.9 Million
Q3 2022 Nov 14, 2022	BUY	$77.78 - $103.92 $130,670 - $174,585	1,680 Added 0.52%	327,624 $26.3 Million
Q2 2022 Aug 12, 2022	BUY	$88.23 - $154.18 $6.52 Million - $11.4 Million	73,872 Added 29.31%	325,944 $31.2 Million
Q1 2022 May 13, 2022	BUY	$121.88 - $150.0 $30.7 Million - $37.8 Million	252,072 New	252,072 $37.4 Million
Q3 2018 Nov 14, 2018	SELL	$73.09 - $81.64 $5.91 Million - $6.6 Million	-80,891 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$61.34 - $76.43 $9.67 Million - $12 Million	-157,583 Reduced 66.08%	80,891 $5.92 Million
Q1 2018 May 15, 2018	SELL	$50.61 - $64.53 $1.56 Million - $1.98 Million	-30,756 Reduced 11.42%	238,474 $15.1 Million
Q4 2017 Feb 14, 2018	SELL	$49.3 - $54.24 $59,160 - $65,088	-1,200 Reduced 0.44%	269,230 $13.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	270,430	270,430 $13.8 Million

Others Institutions Holding CNMD

# of Institutions

307

Shares Held

33.1M

Call Options Held

123K

Put Options Held

24.2K

Black Rock Inc. New York, NY

4.99M
Shares

$351 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.53M
Shares

$248 Million
0.0% of portfolio
Earnest Partners LLC Atlanta, GA

2.78M
Shares

$196 Million
0.91% of portfolio
Capital Research Global Investors Los Angeles, CA

1.54M
Shares

$109 Million
0.02% of portfolio
Bank Of America Corp Charlotte, NC

1.37M
Shares

$96.4 Million
0.01% of portfolio

View Full List

About CONMED Corp

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.14B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

More about CNMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account